Jubilant Life Sciences’ material wholly owned subsidiary -- Jubilant Pharma, through one of its wholly owned subsidiaries, has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the USFDA for its Solid Dosage Facility at Salisbury, Maryland USA in respect of the inspection conducted by the regulatory agency from February 24, 2020 to February 28, 2020. With the receipt of the EIR, the inspection stands successfully closed.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.
